Search results
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 months agoAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2023 Earnings Call Transcript February 15, 2024...
The Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) First-Quarter Results Are Out And Analysts Have...
Simply Wall St. via Yahoo Finance· 1 month agoAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) just released its latest first-quarter results and...
Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Profit Outlook
Simply Wall St. via Yahoo Finance· 10 months agoAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is possibly approaching a major achievement in its...
Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 1 month agoAlnylam Pharmaceuticals Inc (NASDAQ:ALNY) showcases robust revenue growth with a 54.8% increase in...
Alnylam Pharmaceuticals Inc (ALNY) Reports Strong Growth in 2023, Aiming for Continued Success ...
GuruFocus.com via Yahoo Finance· 4 months agoRevenue Growth: Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) reported a 39% increase in annual global...
Is There An Opportunity With Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 44% Undervaluation?
Simply Wall St. via Yahoo Finance· 1 year agoHow far off is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) from its intrinsic value? Using the most...
Unpleasant Surprises Could Be In Store For Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Shares
Simply Wall St. via Yahoo Finance· 1 year agoAlnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) price-to-sales (or "P/S") ratio of 20.1x might make it...
Investors in Alnylam Pharmaceuticals (NASDAQ:ALNY) have seen strong returns of 121% over the past...
Simply Wall St. via Yahoo Finance· 8 months agoAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shareholders might be concerned after seeing the share...
Alnylam Pharmaceuticals Inc (ALNY) Reports 35% YoY Growth in Q3 2023 Net Product Revenues
GuruFocus.com via Yahoo Finance· 7 months agoAlnylam Pharmaceuticals Inc (NASDAQ:ALNY) reported Q3 2023 global net product revenues of $313...
Why Alnylam Pharmaceuticals Stock Is Sinking Today
Motley Fool via Yahoo Finance· 4 months agoShares of Alnylam Pharmaceuticals (NASDAQ: ALNY) were sinking 9.5% lower as of 11:27 a.m. ET on Thursday after falling as much as 12.6% earlier in the...